A Year After Approval, Gene-Therapy Cure Gets Its First Customer
by from MIT Technology Review on (#2N5JP)
GlaxoSmithKline says it has treated a child with Strimvelis, its gene therapy for immune deficiency.GlaxoSmithKline says it has treated a child with Strimvelis, its gene therapy for immune deficiency.